1.13 USD
▼-0.04-3.42%
盘后 1.14 0.00%
2026-09-16
市值
$77.72M
市盈率
—
EPS
-1.29
股息率
—
52 周区间
0.89 – 2.09
成交量
20.51K
Beta
-0.25
目标价
—
52W 低 0.8952W 高 2.09
价格走势
公司简介
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson’s disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer’s disease and Progeria. The company was formerly known as Metallo The...